These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36419466)

  • 1. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergent inequity of glycaemic metrics for Māori children with type 1 diabetes is negated by early use of continuous glucose monitoring.
    Stedman L; Williman J; Burnside M; Davies H; Jefferies C; Marsters B; Paul R; Wheeler B; Wiltshire E; de Bock M
    N Z Med J; 2024 Jul; 137(1598):14-21. PubMed ID: 38963927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
    Brown RE; Chu L; Norman GJ; Abitbol A
    Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models.
    Lomax KE; Taplin CE; Abraham MB; Smith GJ; Haynes A; Zomer E; Ellis KL; Clapin H; Zoungas S; Jenkins AJ; Harrington J; de Bock MI; Jones TW; Davis EA
    Front Endocrinol (Lausanne); 2023; 14():1178958. PubMed ID: 37670884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Observational Crossover Study of People Using Real-Time Continuous Glucose Monitors Versus Self-Monitoring of Blood Glucose: Real-World Evidence Using EMR Data From More Than 12,000 People With Type 1 Diabetes.
    Noor N; Norman G; Sonabend R; Chao L; Kamboj M; Golden L; Bekx MT; Hseih S; Levy C; Sanchez J; Rapaport R; Ebekozien O
    J Diabetes Sci Technol; 2023 Jun; ():19322968231178017. PubMed ID: 37264642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study.
    Lever CS; Williman JA; Boucsein A; Watson A; Sampson RS; Sergel-Stringer OT; Keesing C; Chepulis L; Wheeler BJ; de Bock MI; Paul RG
    J Diabetes Metab Disord; 2023 Dec; 22(2):1779-1792. PubMed ID: 37969919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population.
    Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T
    Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
    Rotondi MA; Wong O; Riddell M; Perkins B
    Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study.
    Taylor PJ; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Wittert G; Brinkworth GD
    Diabetes Ther; 2019 Apr; 10(2):509-522. PubMed ID: 30706365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?
    Elbalshy M; Boucher S; Galland B; Haszard JJ; Crocket H; Wiltshire E; Jefferies C; de Bock MI; Tomlinson P; Jones S; Wheeler BJ
    J Diabetes Metab Disord; 2020 Dec; 19(2):1647-1658. PubMed ID: 33553041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and incidence of type 1 diabetes in children aged 0-14 years old in New Zealand in 2021.
    Wu R; Burnside M; Davies H; Jefferies C; Wheeler B; Paul R; Wiltshire E; de Bock M; Williman J
    J Paediatr Child Health; 2023 Mar; 59(3):519-525. PubMed ID: 36708362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemia and utilisation of technology across the lifespan of adults with type 1 diabetes: Results of the Australian National Diabetes Audit (ANDA).
    Pease A; Szwarcbard N; Earnest A; Andrikopoulos S; Wischer N; Zoungas S
    Diabetes Res Clin Pract; 2021 Jan; 171():108609. PubMed ID: 33310120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.